Google To Spend $250M To End Investor Suit Over Pharma Ads

Google Inc. has agreed to spend a total of $250 million on product quality control to end a suit brought by shareholders after its $500 million settlement with the U.S. government for allowing Canadian pharmaceutical companies to advertise on its site, according to documents filed in California federal court Thursday.